Valion Bio, Inc. (VBIO)
NASDAQ: VBIO · Real-Time Price · USD
0.8597
-0.0203 (-2.31%)
At close: May 18, 2026, 4:00 PM EDT
0.8350
-0.0247 (-2.87%)
After-hours: May 18, 2026, 4:53 PM EDT

Valion Bio Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
May '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
343000
Market Cap Growth
-2.43%22.13%24771.10%-56.70%-83.51%-
Enterprise Value
12.495.181.28-3.21-3.12-12.25
Last Close Price
0.861.455.8930.601087.836596.00
PE Ratio
--0.18-0.30-0.170.00-0.01
PS Ratio
---0.010.020.15
PB Ratio
0.230.241.290.000.010.01
P/TBV Ratio
0.130.100.670.400.010.01
P/FCF Ratio
--0.57-0.570.000.00-0.03
P/OCF Ratio
--0.57-0.570.000.00-0.03
EV/Sales Ratio
----2.73-1.70-9.74
EV/EBITDA Ratio
--0.66-0.290.390.312.18
EV/EBIT Ratio
--0.66-0.290.390.312.17
EV/FCF Ratio
--0.74-0.220.370.352.18
Debt / Equity Ratio
0.890.2700.050.100.04
Debt / EBITDA Ratio
-1.42-0.82--0.04-0.05-0.13
Debt / FCF Ratio
-1.53-0.92--0.04-0.06-0.13
Net Debt / Equity Ratio
0.89-0.37-0.79-0.84-0.82-0.92
Net Debt / EBITDA Ratio
-0.820.780.450.370.302.18
Net Debt / FCF Ratio
-0.880.880.350.350.332.19
Asset Turnover
-000.210.180.15
Inventory Turnover
--01.102.393.87
Quick Ratio
2.7619.577.362.551.9310.72
Current Ratio
3.3120.139.703.322.8311.72
Return on Equity (ROE)
-59.54%-59.87%-146.20%-228.68%-119.47%-140.45%
Return on Assets (ROA)
-34.45%-45.90%-112.41%-149.47%-96.58%-68.00%
Return on Invested Capital (ROIC)
-50.95%-83.71%-812.34%-1377.61%-1225.49%-1161.44%
Return on Capital Employed (ROCE)
-36.14%-47.16%-142.30%-212.69%-113.37%-80.05%
Earnings Yield
-508.34%-540.69%-334.13%-577.78%-32605.10%-12525.80%
FCF Yield
-418.04%-175.66%-174.53%-65427.70%-29317.90%-3038.64%
Buyback Yield / Dilution
-324.89%-302.11%-516.01%-163790.66%-177.04%-51.67%
Total Shareholder Return
-324.89%-302.11%-516.01%-163790.66%-177.04%-51.67%
Updated May 14, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q